| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8653361 | Annals of Vascular Surgery | 2018 | 9 Pages |
Abstract
Heparin-bonded ePTFE graft provides a thromboresistant surface and reduced anastomotic intimal hyperplasia at 2 years. The stable heparin bioactivity of the Propaten graft confers an advantage in long-term graft patency.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
John Freeman, Aaron Chen, Roy J. Weinberg, Tamuru Okada, Changyi Chen, Peter H. Lin,